Neurological Synergy
The CagriSema combination — the most powerful weight loss stack in clinical trials.
GLP-1 (Semaglutide) and Cagrilintide work through complementary neurological mechanisms. GLP-1 (Semaglutide) (glp-1 receptor agonist that delays gastric emptying and activates hypothalamic satiety centers to suppress appetite.) and Cagrilintide (long-acting amylin analog that activates amylin receptors in the hypothalamus to reduce food intake and slow gastric emptying.) address different aspects of cognitive function, making their combination particularly effective for comprehensive neurological optimization.
Combined Protocol
| Compound | Dose | Frequency | Delivery |
|---|---|---|---|
| GLP-1 (Semaglutide) | 0.25mg - 2.4mg | Weekly | Metabolic Cognition |
| Cagrilintide | 0.3mg - 2.4mg | Weekly | Metabolic Cognition |
Get This Protocol
Alukard provides physician-supervised GLP-1 (Semaglutide) + Cagrilintide cognitive protocols with GMP-certified compounds.
Get ProtocolStart Your Cognitive Protocol for GLP-1 (Semaglutide) + Cagrilintide Stack
Alukard provides physician-supervised cognitive health protocols with GMP-certified compounds and comprehensive neurological assessments.
HIPAA Compliant · GMP Certified · Physician Supervised